SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-084191
Filing Date
2013-11-13
Accepted
2013-11-13 16:10:49
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-22691_110q.htm 10-Q 976035
2 EX-31.1 a13-22691_1ex31d1.htm EX-31.1 9033
3 EX-31.2 a13-22691_1ex31d2.htm EX-31.2 9118
4 EX-32.1 a13-22691_1ex32d1.htm EX-32.1 5354
5 EX-32.2 a13-22691_1ex32d2.htm EX-32.2 5327
  Complete submission text file 0001104659-13-084191.txt   5248990

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fate-20130930.xml EX-101.INS 713700
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fate-20130930.xsd EX-101.SCH 28686
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fate-20130930_cal.xml EX-101.CAL 40833
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fate-20130930_def.xml EX-101.DEF 140927
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT fate-20130930_lab.xml EX-101.LAB 520145
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fate-20130930_pre.xml EX-101.PRE 251411
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-36076 | Film No.: 131214720
SIC: 2836 Biological Products, (No Diagnostic Substances)